Hairy Cell Leukemia
Author and Disclosure Information [Show]

Leslie A. Andritsos, MD
Associate Professor of Medicine, Division of Hematology, Department of Internal Medicine, The Ohio State University, Wexner Medical Center, James Cancer Center and Solove Research Institute, Columbus, OH

Mirela Anghelina, MD
Non-Therapeutic Clinical Trials, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH

Kelly E. Johnson, PhD
Non-Therapeutic Clinical Trials, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH

Question 1 of 5

Questions 1 and 2 refer to the following case:

A 72-year-old man with no significant past medical history presents for evaluation of fatigue. On physical exam he appears pale and has palpable cervical lymphadenopathy as well as splenomegaly. Laboratory testing reveals a white blood cell (WBC) count of 35,000/µL with a hemoglobin level of 5.6 g/dL and a platelet count of 86 × 103/µL. Review of the peripheral blood smear shows a predominance of WBCs with pale blue cytoplasm, prominent nucleoli, and serrated hair-like projections.

Which of the following is the most appropriate next step in the management of this patient?

Inform him that he has hairy cell leukemia (HCL)

Initiate therapy with cladribine

Perform a bone marrow aspiration and biopsy

Refer him to a tertiary medical center

Hospital Physician: Hematology/Oncology. 2017 November;12(6)

This quiz is not accredited for CME.

More from Board Review Questions: Hematology/Oncology


Autoimmune Hemolytic Anemia
Gastrointestinal Stromal Tumors
Testicular Cancer
Management of Advanced Melanoma
Castration-Resistant Prostate Cancer
Transfusion Reactions (part 2)
Transfusion Reactions (part 1)
Plasma Cell Disorders (part 3)
Plasma Cell Disorders (part 2)
Chronic Myeloid Leukemia
Aplastic Anemia
Small Cell Lung Cancer
Management of Metastatic Gastric Cancer
Transfusion Medicine
Management of Colorectal Cancer in Older Adults
Urothelial Carcinoma: Muscle-Invasive and Metastatic Disease
Acute Myeloid Leukemia
Pancreatic Adenocarcinoma: Advanced Unresectable and Metastatic Disease
HER2-Positive Breast Cancer
Aggressive B-Cell Non-Hodgkin Lymphoma
Von Willebrand Disease: Assessment and Diagnostic Testing
Von Willebrand Disease: Clinical Management
Pancreatic Adenocarcinoma: Neoadjuvant and Adjuvant Treatment
Late Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Polycythemia Vera and Essential Thrombocythemia: Current Management
Treatment of Biliary Tract Cancers
Early Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Genomic Testing in Women with Early-Stage Hormone Receptor–Positive, HER2-Negative Breast Cancer
Immune Thrombocytopenia
Cancer-Related Fatigue
Disseminated Intravascular Coagulation
Advanced Stage and Relapsed/Refractory Hodgkin Lymphoma
Adjuvant Chemotherapy for Colon Cancer
Molecular Markers and Targeted Therapies in the Management of Non-Small Cell Lung Cancer
Metastatic Cutaneous Melanoma: Targeted Therapy and Immunotherapy
Thrombosis in Pregnancy
Locally Advanced Pancreatic Cancer
Early-Stage Hodgkin Lymphoma
Neoadjuvant and Adjuvant Therapy for Gastric Cancer
Hemophilia A and B
Mantle Cell Lymphoma
Soft Tissue Sarcoma
Sickle Cell Disease
Renal Cell Carcinoma
Management of Locally Advanced Rectal Adenocarcinoma
Adjuvant Systemic Therapy for Early-Stage Breast Cancer
Chronic Myeloid Leukemia
Plasma Cell Disorders
Myelodysplastic Syndromes
Acute and Chronic Graft-versus-Host Disease